MorphoSys
Updated: January 13, 2026
Founders: Andreas Plückthun, Simon E. Moroney
Country: Germany | Funding: $748.1M (+)
MorphoSys' mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Our focus is on cancer. Acquired by Novartis
MorphoSys' mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Our focus is on cancer. Acquired by Novartis
